Key facts
- This page summarizes Chaim Hurvitz's Form 4 filing for NRX Pharmaceuticals, Inc. (NRXP).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 11 Sep 2023, 09:15.
Chaim Hurvitz - 30 Aug 2023 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)
- Role
- Director
- Signature
- /s/ Chaim Hurvitz
- Issuer symbol
- NRXP
- Transactions as of
- 30 Aug 2023
- Net transactions value
- +$20,125
- Form type
- 4
- Filing time
- 11 Sep 2023, 09:15:13 UTC
- Previous filing
- 27 Sep 2023
- Next filing
- 25 Jun 2024
- SEC
- View on sec.gov
Key filing fact
Chaim Hurvitz filed Form 4 for NRX Pharmaceuticals, Inc. (NRXP) on 11 Sep 2023.
Change
- Previous filing in this sequence was filed on 27 Sep 2023.
- Current net transaction value: +$20,125.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
NRXP
transaction
Common Stock, par value $0.001 per share
Purchase
- Transaction value
- $20,125
- Shares
- +70,000
- Change %
- +14%
- Price
- $0.2875
- Shares after
- 570,000
- Date
- 30 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
NRXP
holding
Common Stock, par value $0.001 per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,436,350
- Date
- 30 Aug 2023
- Ownership
- By Shirat HaChaim Ltd.
- Footnotes
- F2
NRXP
holding
Common Stock, par value $0.001 per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 208,443
- Date
- 30 Aug 2023
- Ownership
- By CH Health-Private Venture Capital Ltd.
- Footnotes
- F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares of the Common Stock and prices at which the transaction was effected. |
| F2 | Chaim Hurwitz is the owner of Shirat HaChaim Ltd. |
| F3 | Chaim Hurwitz is the owner of CH Health-Private Venture Capital Ltd. |